Browse > Article

Ginsan Improved Th1 Immune Response Inhibited by Gamma Radiation  

Han Seon Kyu (Laboratory of Immunology, Korea Institute of Radiological and Medical Sciences, Bioanalysis and Biotransformation Research Center, Korea Institute of Science and Technology)
Song Jie Young (Laboratory of Immunology, Korea Institute of Radiological and Medical Sciences)
Yun Yeon Sook (Laboratory of Immunology, Korea Institute of Radiological and Medical Sciences)
Yi Seh Yoon (Technical Research Institute, Microbia Corp, College of Natural Science, Suwon University)
Publication Information
Archives of Pharmacal Research / v.28, no.3, 2005 , pp. 343-350 More about this Journal
Abstract
Gamma radiation causes suppression of the immune function, and immune properties are related to cytokine production. In the present study, the polysaccharide, Ginsan, purified from an ethanol-insoluble fraction of Ginseng (Panax ginseng C.A. Meyer, Araliaceae) water extract was studied to assess its effects on the immunosuppressive activities of gamma radiation. Gin­san was found to stimulate murine normal splenocytes by inducing the mRNA expressions of Th1 and Th2 type cytokines, and also restore the mRNA expression of IFN-$/gamma$, Th1 cytokine, after its inhibition by whole-body gamma irradiation. Therefore, Ginsan was found to restore the T lymphocytes function that had been suppressed by gamma irradiation in allogenic MLR (mixed lymphocyte reactions). However, Ginsan exhibited no excessive stimulatory effects on the control group. The above results indicated that Ginsan may constitute a new noble agent for the improvement of gamma radiation-induced immunosuppression.
Keywords
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
Times Cited By Web Of Science : 12  (Related Records In Web of Science)
Times Cited By SCOPUS : 12
연도 인용수 순위
1 Ballas, Z. K., Rasmussen, W., and Van Otegham, J. K., Lymphokine-activated killer (LAK). II. Delineation of distinct murine LAK-precursor subpopulation. J. Immunol., 138, 1647-1652 (1987)
2 Gao, Q. P., Kiyohara, H., Cyong, J., and Yamada, H., Chemical properties and anticomplementary activities of heteroglycans from the leaves of panax ginseng. Planta Med., 57, 132-136 (1991)   DOI   ScienceOn
3 Kim, Y. S., Kang, K. S., and Kim, S. I., Study on antitumor and immunomodulating activities of polysaccharides fraction from parax ginsans: Comparison of effect of neutral and acidic polysaccharide fraction. Arch. Pharm. Res., 13, 330-337 (1990)   DOI   ScienceOn
4 Murren, J. R. and Buzaid, A. C., The role of interferons in the treatment of malignant neoplasms. Yale J. Biol. Med., 62, 271-290 (1989)
5 Kim, S. I., Kang, K. S., and Lee, Y. H., Panaxyne epoxide, a new cytotoxic polyne from panax ginseng root against L1210 cells. Arch. Pharm. Res., 12, 48-51 (1989)   DOI   ScienceOn
6 Talmadge, J. E. and Herberman, R. B., The preclinical screening laboratory: Evaluation of immunomodulatory and therapeutic properties of biological response modifiers. Cancer Treatment Reports, 70, 171-182 (1986)   PUBMED
7 Grimm, E. A., Mazumder, A., Zhang, Z., and Rosenberg, S. A., Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin-2 activated autologous human peripheral blood lymphocytes. J. Exp. Med., 155, 1823-1841 (1982)   DOI   ScienceOn
8 Khan, I. A. and Casciotti, L., IL-15 prolongs the duration of CD8+ T cell-mediated immunity in mice infected with a vaccine strain of Toxoplasma gondii. J. Immunol., 163(8), 4503-4509 (1999)
9 Chen, Y. M, Ting, C. C., Peng, J. W., Yang, W. K., Yang, K. Y., Tsai, C. M., and Perng, R. P., Restoration of cytotoxic T lymphocyte function in malignant pleural effusion: interleukin- 15 vs. interleukin-2. J. Interferon Cytokine Res., 20(1), 31-39 (2000)   DOI   ScienceOn
10 Talmadge, J. E., Fidler, I. J., and Oldham, R. K., The NCI preclinical screen of biological response modifiers. Behring Inst. Mitt., 74, 189-194 (1984)
11 Galdiero, M., Cipollaro del'Ero, G., Folgore, A., Cappello, M., Giobbe, A., and Sasso, F. S., Effects of irradiation doses on alteration in cytokine release by monocytes and lymphocytes. J. Med., 25, 23-40 (1994)
12 Doherty, P. C., Grosveld, G. C., and Ihle, J. N., Requirement for Stat4 in interleukin-12-mediated response of natural killer and T cells. Nature, 382, 171-174 (1996)   DOI   ScienceOn
13 Mule, J. J., Shu, S., and Rosenberg, S., The antitumor efficacy of lymphokine-activated killer cells and recombinant interleukin-2 in vivo. J. Immunol., 135, 646-652 (1985)
14 Pharmacognosy, Korea association of pharmacognosy, hakchang press (1995)
15 Shuat, K., Horvath, C. M., Huang, L. H. T., Qureshi, S. A., Cowburn, D., and Darnell, J. E., Interferon activation of transcription factor Stat1 involves dimerization through SH2- Phosphotyrosyl peptide interactions. Cell, 76, 821-828 (1994)   DOI   ScienceOn
16 Yun, Y.-S., Lee, Y.-S., Jo, S.-K., and Jung, I.-S., Inhibition of autochthonous tumor by ethanol insoluble fraction from panax ginseng as an immunostimulator. Planta medica, 59, 521-524 (1993)   DOI   ScienceOn
17 Singh, V. K., George, C. X., Singh, N., Agarwal, S. S., and Gupta, B. M., Combined treatment of mice with Panax ginseng extract and interferon inducer. Planta Med., 47, 234- 236 (1983)   DOI   ScienceOn
18 Smalley, R. V. and Oldham, R. K., Phase I trials of biological response modifiers. Drugs Exptl. Clin. Res., 12, 31-39 (1986)
19 Song, J. Y., Han, S. K., Son, E. H., Pyo, S. N., Yun, Y. S., Yi, S. Y., Induction of secretory and tumoricidal activities in peritoneal macrophages by Ginsan. Int. Immunopharmacol., 2(7), 857-865 (2002)   DOI   ScienceOn
20 Han, S. K., Song, J. Y., Yun, Y. S., and Yi, S. Y., Gamma irradiation reduced IFN-gamma expression, STAT-1 signal, and cell-mediated immunity. J. Biochem. Mol. Biol., 35(6), 583-589 (2002)   DOI   PUBMED
21 Yang, J. C., Mule, J. J., and Rosenberg, S., Murine lymphokineactivated killer (LAK) cells: phenotypic characterization of the precursors and effector cells. J. Immunol., 137, 715-722 (1986)
22 Wiltrout, R. H. and Hornung, R. L., natural products as antitumor agents: direct versus indirect mechanisms of activity of flavonoids. J. Natl.Cancer Institute, 80, 220-222 (1988)   DOI   PUBMED
23 Lee, Y. S., Jung, I. S., Lee, I. R., Kim, K. W., Hong, W. S., and Yun, Y. S., Activation of Multiple Effecter pathway of immune system by the antineoplastic immunostimulator acldic polysaccharide ginsan isolated from panax ginseng. Anticancer Res., 17, 323-331 (1997)
24 Sredni, B., Caspi, R.R., Klein, A., Kalechman, Y., Danziger, Y., BenYa'akov, M., Tamari, T., Shalit, F., and Albeck, M., A new immunomodulating compound (AS101) with potential therapeutic application. Nature, 330, 173-176 (1987)   DOI   ScienceOn
25 Yanagawa, E., Yasumoto, K., Ohta, M., Nomoto, K., Azuma, I., and Yamamura, Y., Comparative study on antitumor effect of cell-wall skeleton of Mycobacterium bovis BCG and Nocardia rubra, with reference to T-cell dependency and independency. JPN. J. Cancer Res., 70, 141-146 (1979)
26 Oldham, R. K., Biological response modifiers program and chemotheraphy. Int. J. Tissue React., 4, 173-188 (1982)
27 Maeda, Y. Y., Watanabe, S. T., Chilara, G., and Rokutanda, M., T-cell mediated vascular dilation and hemorrhage induced by antitumor polysaccharide. Intl. J. Immunopharmacol, 6, 493- 501 (1984)   DOI   ScienceOn
28 Ochoa, A. C., Gromo, G., Alter, B. J., Sondel, P. M., and Bach, F. II., Long-term growth of lymphokine-activated killer (LAK) cells: role of anti-CD3, bIL-1, interferon-g and -b. J. immunol., 138, 2728-2733 (1987)
29 Song, J. Y., Han, S. K., Bae, K. G., Lim, D. S., Son, S. J., Jung, I. S., Yi, S. I., and Yun, Y. S., Radioprotective effects of Ginsan, an immunomodulator. Radiat. Res., 159(6), 768-774 (2003)   DOI   ScienceOn
30 Wimer, B. M., The ideal biological response modifier. Mol. Biother., 1, 311-317 (1989)
31 Uchida and Micksche, M., In vitro augmentation of natural killing activity by OK-432. Int. J. Immunopharmac., 3, 365-375 (1981)   DOI   ScienceOn
32 Strander, H., Clinical effects of interferon therapy with special emphasis on antitumor efficacy. Acta Oncologica, 28, 355- 362 (1989)   DOI   ScienceOn
33 Rosenberg, S., Lotze, M., Muul, L., Leitman, S., Chang, A., Ettinghausen, S., Matury, Y., Skibber, J., Shilon, E., Vetto, J., Seipp, C., Simpson, C., and Reichert, C., Observation on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. N. Engl. J. Med., 313, 1485-1492 (1985)